Drug Pipeline News

September 28th 2023

A nationwide recall has been issued for ibrexafungerp products after a potential cross contamination with a non-antibacterial ß-lactam drug substance was discovered.

September 26th 2023

Ahead of the first fall and winter virus seasons in which vaccines are available for COVID-19, influenza, and respiratory syncytial virus (RSV), the Centers for Disease Control and Prevention is recommending Pfizer’s maternal vaccine to protect newborns from severe RSV illness.

August 15th 2023

If approved, cefepime-taniborbactam will provide treatment against complicated urinary tract infections in adults.

August 9th 2023

Daré Bioscience has published the results of a phase ½ trial on DARE-HRT1, indicating efficacy against moderate-to-severe vasomotor symptoms.